» Authors » Lynne L Johnson

Lynne L Johnson

Explore the profile of Lynne L Johnson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 932
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen Y, Bremner L, Shetty M, Castillo M, Cappell J, Leb J, et al.
Circ Cardiovasc Imaging . 2025 Mar; :e017567. PMID: 40079120
Background: Cardiac diagnostic testing continues to evolve, and controversies remain regarding the optimal utilization of different procedures. We sought to evaluate changes in long-term utilization trends for a wide range...
2.
Chan N, Einstein A, Griffin J, Rosenblum H, Teruya S, Cuomo M, et al.
J Nucl Cardiol . 2023 Jun; 30(6):2531-2539. PMID: 37311914
Introduction: Technetium-labeled bone-avid radiotracers can be used to diagnose transthyretin cardiac amyloidosis (ATTR-CA). Extracardiac uptake of technetium pyrophosphate (Tc-99m PYP) in this context has not been extensively explored and its...
3.
Pandey S, Teruya S, Rodriguez C, DeLuca A, Kinkhabwala M, Johnson L, et al.
J Nucl Cardiol . 2023 Feb; 30(4):1414-1419. PMID: 36823486
Background: The optimal heart-to-contralateral chest (H/CL) ratio threshold for non-invasive diagnosis of transthyretin cardiac amyloidosis (ATTR-CA) using Tc pyrophosphate (PYP) imaging in a population with low pretest probability is not...
4.
Johnson L, Tekabe Y, Zelonina T, Ma X, Zhang G, Goldklang M, et al.
Respir Res . 2023 Jan; 24(1):21. PMID: 36670409
Background: Receptor for Advanced Glycated Endproducts (RAGE) plays a major role in the inflammatory response to infectious and toxin induced acute lung injury. We tested the hypothesis that a RAGE...
5.
Clerkin K, Topkara V, Farr M, Jain R, Colombo P, Restaino S, et al.
J Am Coll Cardiol . 2022 Oct; 80(17):1617-1628. PMID: 36265957
Background: Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both epicardial coronary arteries and the microvasculature. A leading cause of post-transplant mortality, CAV affects 50% of heart transplant recipients...
6.
Johnson J, Takebe Y, Zhang G, Ober R, McLuckie A, Niedt G, et al.
Int Wound J . 2022 Aug; 20(3):678-686. PMID: 35945908
Receptor for Advanced Glycated End-products (RAGE) is highly expressed in diabetes and impairs wound healing. We proposed that administering an antibody that blocks RAGE will hasten the healing of dorsal...
7.
Poterucha T, Elias P, Ruberg F, DeLuca A, Kinkhabwala M, Johnson L, et al.
JACC Cardiovasc Imaging . 2021 May; 14(10):2042-2044. PMID: 34023264
No abstract available.
8.
Johnson L, Johnson J, Ober R, Holland A, Zhang G, Backer M, et al.
J Am Heart Assoc . 2020 Dec; 10(1):e016696. PMID: 33327730
Background Expression of receptor for advanced glycation end products (RAGE) plays an important role in diabetic peripheral artery disease. We proposed to show that treatment with an antibody blocking RAGE...
9.
Poterucha T, Elias P, Bokhari S, Einstein A, DeLuca A, Kinkhabwala M, et al.
JACC Cardiovasc Imaging . 2020 Nov; 14(6):1221-1231. PMID: 33221204
Objectives: This study aimed to characterize trends in technetium Tc 99m pyrophosphate (Tc-PYP) scanning for amyloid transthyretin cardiac amyloidosis (ATTR-CA) diagnosis, to determine whether patients underwent appropriate assessment with monoclonal...
10.
Poterucha T, Elias P, Ruberg F, DeLuca A, Kinkhabwala M, Johnson L, et al.
J Nucl Cardiol . 2020 Oct; 29(3):1478-1480. PMID: 33118142
No abstract available.